Delivery Order SPE2DB22D1041-SPE2DB24FTZM5
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $9.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S. The contract has a potential value of $1,763.88 and a performance period through January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) that the company holds with DLA. The IDC has a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE HCT 10-160-25 MG TAB 30S. This $1,225.14 award has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) it holds with DLA, potentially valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,966.10 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of February 8, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of EXFORGE 10-320 mg tablets. The contract has a potential value of $10,323.09 and a period of performance through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This contract appears to be issued under a larger...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.00 firm fixed-price delivery order is for the supply of EXFORGE 10-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply EXFORGE 10-160 mg tablets. The $2,665.30 firm fixed price contract has an ultimate completion date of October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.89, is for the supply of 4568185974 - EXFORGE 10-160 MG TABLET 30S, a medication used to treat high blood pressure. The award is a firm-fixed price contract with a period of performance through May 9, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $1,020.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense globally. The current delivery order is for the medication EXFORGE HCT 10-320-25 MG TAB...